APA (7th ed.) Citation

Mueller, C., Haydon, A., Atkinson, V., Prithviraj, P., Triebel, F., Brignone, C., . . . Roy, A. Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Mueller, Christian, Andrew Haydon, Victoria Atkinson, Prashanth Prithviraj, Frederic Triebel, Chrystelle Brignone, Adnan Khattak, Melissa Eastgate, and Amitesh Roy. Eftilagimod Alpha, a Soluble Lymphocyte Activation Gene-3 (LAG-3) Protein Plus Pembrolizumab in Patients with Metastatic Melanoma. BMJ Publishing Group.

MLA (9th ed.) Citation

Mueller, Christian, et al. Eftilagimod Alpha, a Soluble Lymphocyte Activation Gene-3 (LAG-3) Protein Plus Pembrolizumab in Patients with Metastatic Melanoma. BMJ Publishing Group.